1. Beloc Duriles
2. Beloc-duriles
3. Betaloc
4. Betaloc Astra
5. Betaloc-astra
6. Betalok
7. Cgp 2175
8. Cgp-2175
9. Cgp2175
10. H 93 26
11. H 93-26
12. H 9326
13. Lopressor
14. Metoprolol
15. Metoprolol Cr Xl
16. Metoprolol Cr-xl
17. Metoprolol Tartrate
18. Seloken
19. Spesicor
20. Spesikor
21. Toprol
22. Toprol Xl
23. Toprol-xl
1. 98418-47-4
2. Metroprolol Succinate
3. Selozok
4. Toprol Xl
5. Metoprolol (succinate)
6. Seloken-zok
7. H 93/26 Succinate
8. Toprol-xl
9. Metoprolol Hemisuccinate
10. Butanedioic Acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
11. Th25pd4ccb
12. Spesicor Dos
13. Seloken Zoc
14. Beloc- Zok
15. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, Butanedioate (2:1) (salt)
16. Metoprolol Succinate [usan]
17. Unii-th25pd4ccb
18. Metoprololsuccinate
19. Metoprolol Succinate [usan:usp]
20. Toprol Xl (tn)
21. Metoprolol Succinate Extended-release Tablets
22. Metoprolol Succinate (usp)
23. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
24. Dsstox_cid_28652
25. Dsstox_rid_82922
26. Dsstox_gsid_48726
27. Schembl40916
28. Chebi:6905
29. Chembl2356097
30. Dtxsid9048726
31. Metoprolol Succinate [mi]
32. Hms3886g21
33. Bcp02473
34. Metoprolol Succinate [vandf]
35. Tox21_113155
36. Hy-17503a
37. Metoprolol Succinate [mart.]
38. Mfcd23115896
39. S5341
40. Metoprolol Succinate [usp-rs]
41. Metoprolol Succinate [who-dd]
42. 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; Succinic Acid
43. Akos015856332
44. Bcp9000922
45. Ccg-270331
46. Cs-3158
47. Ks-1241
48. Ac-26570
49. Metoprolol Succinate [ep Impurity]
50. Metoprolol Succinate [orange Book]
51. Metoprolol Succinate [ep Monograph]
52. Cas-98418-47-4
53. Metoprolol Succinate [usp Monograph]
54. Ft-0628933
55. Dutoprol Component Metoprolol Succinate
56. D00635
57. Metoprolol Succinate Component Of Dutoprol
58. 418m474
59. A845856
60. Q-201401
61. Q27289962
62. Metoprolol Succinate, United States Pharmacopeia (usp) Reference Standard
63. Bis(1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol); Butanedioic Acid
64. Butanedioic Acid,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
65. (+/-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
66. 123245-49-8
67. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, Butanedioate (2:1) (salt)
| Molecular Weight | 652.8 g/mol |
|---|---|
| Molecular Formula | C34H56N2O10 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 21 |
| Exact Mass | 652.39349599 g/mol |
| Monoisotopic Mass | 652.39349599 g/mol |
| Topological Polar Surface Area | 176 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 308 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 4 | |
|---|---|
| Drug Name | Metoprolol succinate |
| Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
| Active Ingredient | Metoprolol succinate |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
| Market Status | Prescription |
| Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
| 2 of 4 | |
|---|---|
| Drug Name | Toprol-xl |
| Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
| Active Ingredient | Metoprolol succinate |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
| Market Status | Prescription |
| Company | Astrazeneca |
| 3 of 4 | |
|---|---|
| Drug Name | Metoprolol succinate |
| Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
| Active Ingredient | Metoprolol succinate |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
| Market Status | Prescription |
| Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
| 4 of 4 | |
|---|---|
| Drug Name | Toprol-xl |
| Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
| Active Ingredient | Metoprolol succinate |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
| Market Status | Prescription |
| Company | Astrazeneca |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
LOOKING FOR A SUPPLIER?
